Egle Therapeutics
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| First-in-human Trial of EGL-001 in Patients with Selected Advanced And/or Metastatic Solid Tumors (NCT06622486) | Egle Therapeutics | 2024-09-27 |
Track Egle Therapeutics automatically
Every clearance here is in the API, with alerts when new ones post.